Erin F. Cobain, MD is a Clinical Assistant Professor in the Division of Hematology/Oncology, where she specializes in the treatment of patients with breast cancer. She received her undergraduate degree from Davidson College, which she received a B.S. in Biology and graduated cum laude and Phi Beta Kappa. She received her medical degree from the University of Chicago Pritzker School of Medicine. She completed her Internal Medicine residency at the Hospital of the University of Pennsylvania, where she also served as Chief Medical Resident. Dr. Cobain completed her fellowship in Hematology/Oncology at the University of Michigan, where she was also Chief Fellow. She joined the faculty at the University of Michigan in 2016. Dr. Cobain’s research interest is primarily in the application of next-generation sequencing technology in oncology clinical practice.  She also has an interest in the use of tumor biomarkers to direct and personalize patient care. She works in collaboration with the Michigan Oncology Sequencing Center (Mi-OncoSeq program) to study the clinical outcomes of patients with advanced malignancies undergoing comprehensive next-generation sequencing analysis of their tumors.

Next generation sequencing of tumor and blood to identify therapeutic targets for patients with advanced cancer
Next-generation sequencing of matched tumor and normal samples to identify inherited cancer susceptibility
Identification of tumor biomarkers in breast cancer that predict benefit from immunotherapy